Enhancing Domestic Drug Manufacturing Competitiveness Act
Official title: To direct the Comptroller General of the United States to conduct a study to assess the key regulatory barriers that impede the expansion or siting of new pharmaceutical manufacturing facilities in the United States, and for other purposes.
What Do You Think?
How would you vote?
Referandom Vote
Vote to see the result.
How Congress Voted
PendingWhat Happened in Congress?
Not yet voted on the floor.
Where the Bill Stands
- Introduced, done
- Committee, current stage
- Floor Vote, not yet
- Outcome, not yet
Sponsors
Timeline
- Library of CongressIntroduced in House
- House floor actionsReferred to the House Committee on Energy and Commerce.
- Introduced
- Committee

Comments
Comments with insults, hate speech or personal information are removed.